BSE filing, NSE: SYMBIOTEC. Summary written from the filing by ALFA Finder's alert engine.
Symbiotec Pharmalab Ltd: key numbers
- Share price
- ₹1,271.50
- Market cap
- ₹8,170 Cr
- Revenue (annual)
- ₹869.1 Cr
- Net profit (annual)
- ₹109.9 Cr
- Promoter holding
- 33.28%
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Symbiotec Pharmalab Ltd
All →Symbiotec Pharmalab Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹280 Cr (+43%), PAT ₹52 Cr (+169%); H1 revenue ₹498 Cr (+25%), PAT ₹66 Cr (+34%). Capex-led push into DCV injectables and CDMO.
Symbiotec Pharmalab Other Announcement
Symbiotec Pharmalab filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing lists promoter and public holdings with no transaction or corporate event.
Symbiotec Pharmalab Board Meeting Date
Symbiotec Pharmalab schedules a 5 November 2026 board meeting to consider unaudited quarterly and half-year results. No amounts are proposed.
Symbiotec Pharmalab Share Pledge
Promoters of Symbiotec Pharmalab submitted a revised disclosure to update the lender and trustee names for their pledged share encumbrance.
Symbiotec Pharmalab Other Announcement
Symbiotec Pharmalab Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31 of the SEBI LODR Regulations.
Symbiotec Pharmalab Other Announcement
Symbiotec Pharmalab has filed the routine quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ending September 30, 2026.
Other results update announcements
All →Basilic Fly Studio Results Update
Basilic Fly Studio reported Q2 FY27 consolidated revenue of INR 1,074 Mn, up 12.82% YoY, with EBITDA and net profit declining. The filing is a press release on unaudited quarterly and half-year results.
Rashi Peripherals Results Update
Rashi Peripherals posted record Q2 FY27 profit of INR 1,307 million, up 120.8% year-on-year. Half-year net profit rose 94.6% to INR 2,353 million.
Veegaland Developers Results Update
Veegaland Developers reported Q2 FY27 revenue of Rs.106.3 Crore, up 28.7% YoY, with PAT of Rs.16.0 Crore. The figures come from a press release on unaudited results for the quarter ended 30 September 2026.
Healthcare Global Enterprises Results Update
HCG reported Q2 FY27 revenue of INR 7,318 Mn, up 16% YoY, with adjusted EBITDA up 17%. Results cover the quarter and half-year ended September 30, 2026.
Bella Casa Fashion & Retail Results Update
Bella Casa reported H1 FY27 revenue up 20% to Rs 259 crore, with PAT of Rs 6.5 crore. Q2 revenue rose 11% YoY to Rs 139 crore.
GHCL Textiles Results Update
GHCL Textiles released Q2 and H1 FY27 press highlights, showing Q2 revenue up 31% and PAT up 249%. These are reported results highlights, not a new event.